Rucaparib for maintenance treatment of platinum-sensitive, recurrent ovarian carcinoma: Final results of the phase 3, randomized, placebo-controlled ARIEL3 trial

Jonathan A. Ledermann, Amit M. Oza, Domenica Lorusso, Carol Aghajanian, Ana Oaknin, Andrew Dean, Nicoletta Colombo, Johanne I. Weberpals, Andrew R. Clamp, Giovanni Scambia, Alexandra Leary, Robert W. Holloway, Margarita Amenedo Gancedo, Peter C. Fong, Jeffrey C. Goh, David M. O’Malley, Deborah K. Armstrong, Susana Banerjee, Jesús García-Donas, Elizabeth M. Swisher, Coriolan Lebreton, Gottfried E. Konecny, Iain A. McNeish, Clare L. Scott, Lara Maloney, Sandra Goble, Kevin K. Lin, Robert L. Coleman

Open source

DOI: 10.1016/j.ejca.2025.115584
Published: 2025-07
Container: European Journal of Cancer
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.ejca.2025.115584,
  title = {Rucaparib for maintenance treatment of platinum-sensitive, recurrent ovarian carcinoma: Final results of the phase 3, randomized, placebo-controlled ARIEL3 trial},
  author = {Jonathan A. Ledermann and Amit M. Oza and Domenica Lorusso and Carol Aghajanian and Ana Oaknin and Andrew Dean and Nicoletta Colombo and Johanne I. Weberpals and Andrew R. Clamp and Giovanni Scambia and Alexandra Leary and Robert W. Holloway and Margarita Amenedo Gancedo and Peter C. Fong and Jeffrey C. Goh and David M. O’Malley and Deborah K. Armstrong and Susana Banerjee and Jesús García-Donas and Elizabeth M. Swisher and Coriolan Lebreton and Gottfried E. Konecny and Iain A. McNeish and Clare L. Scott and Lara Maloney and Sandra Goble and Kevin K. Lin and Robert L. Coleman},
  year = {2025},
  journal = {European Journal of Cancer},
  doi = {10.1016/j.ejca.2025.115584},
  url = {https://doi.org/10.1016/j.ejca.2025.115584}
}

RIS

TY  - JOUR
TI  - Rucaparib for maintenance treatment of platinum-sensitive, recurrent ovarian carcinoma: Final results of the phase 3, randomized, placebo-controlled ARIEL3 trial
AU  - Jonathan A. Ledermann
AU  - Amit M. Oza
AU  - Domenica Lorusso
AU  - Carol Aghajanian
AU  - Ana Oaknin
AU  - Andrew Dean
AU  - Nicoletta Colombo
AU  - Johanne I. Weberpals
AU  - Andrew R. Clamp
AU  - Giovanni Scambia
AU  - Alexandra Leary
AU  - Robert W. Holloway
AU  - Margarita Amenedo Gancedo
AU  - Peter C. Fong
AU  - Jeffrey C. Goh
AU  - David M. O’Malley
AU  - Deborah K. Armstrong
AU  - Susana Banerjee
AU  - Jesús García-Donas
AU  - Elizabeth M. Swisher
AU  - Coriolan Lebreton
AU  - Gottfried E. Konecny
AU  - Iain A. McNeish
AU  - Clare L. Scott
AU  - Lara Maloney
AU  - Sandra Goble
AU  - Kevin K. Lin
AU  - Robert L. Coleman
PY  - 2025
JO  - European Journal of Cancer
DO  - 10.1016/j.ejca.2025.115584
UR  - https://doi.org/10.1016/j.ejca.2025.115584
ER  -

APA

Ledermann, J. A., Oza, A. M., Lorusso, D., Aghajanian, C., Oaknin, A., Dean, A., Colombo, N., Weberpals, J. I., Clamp, A. R., Scambia, G., Leary, A., Holloway, R. W., Gancedo, M. A., Fong, P. C., Goh, J. C., O’Malley, D. M., Armstrong, D. K., Banerjee, S., García-Donas, J., Swisher, E. M., Lebreton, C., Konecny, G. E., McNeish, I. A., Scott, C. L., Maloney, L., Goble, S., Lin, K. K., & Coleman, R. L. (2025). Rucaparib for maintenance treatment of platinum-sensitive, recurrent ovarian carcinoma: Final results of the phase 3, randomized, placebo-controlled ARIEL3 trial. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2025.115584

Source records

crossref · retrieved 2026-09-27T09:46:53.550Z